Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,990.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 8,895
  • Market Cap: £207.85m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 518,176 £20,675,222
Ian James Nicholson 15,500 £618,450

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £39,301,500
Liontrust Investment Partners LLP 522,952 £20,865,785
Miton Group plc 508,135 £20,274,586
The Diverse Income Trust plc 302,300 £12,061,770
Wasatch Advisors, Inc. 265,000 £10,573,500
Canaccord Genuity Group Inc 259,940 £10,371,606
Gresham House Asset Management Limited 259,116 £10,338,728
Adrian Williams 253,372 £10,109,543
Danske Bank A/S 168,132 £6,708,467

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,990.00p
Change Today 10.00p
% Change 0.25 %
52 Week High 4,500.00
52 Week Low 3,800.00
Volume 8,895
Shares Issued 5.21m
Market Cap £207.85m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.31% below the market average85.31% below the market average85.31% below the market average85.31% below the market average85.31% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average
Price Trend
58.13% below the market average58.13% below the market average58.13% below the market average58.13% below the market average58.13% below the market average
40.98% below the sector average40.98% below the sector average40.98% below the sector average40.98% below the sector average40.98% below the sector average
Income Not Available
Growth
78.12% above the market average78.12% above the market average78.12% above the market average78.12% above the market average78.12% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 28-Jul-2021

Time Volume / Share Price
16:35 1,318 @ 3,988.32p
16:35 513 @ 3,990.00p
16:08 24 @ 4,011.50p
14:55 250 @ 4,030.00p
14:31 49 @ 4,030.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page